维普中文期刊产品整合服务
5篇 您的检索式:作者名="Smilde JG"
    题名 作者 年代 出处 被引量
1Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with lype 2 diabetes : the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN) 显示文摘Knopp RH d'Emden M Smilde JG 2006Diabetes Care2006,29,7:1
2Efficacy and safety of atorvastatin in the prevention of cardiovascular endpoints in subjects with type2diabetes:The Atorvastatin Study for prevention of coronary heart disease endpoints in Non-in-sulin-dependent diabetes mellitus(ASPEN)显示文摘Knopp RH d'Emden M Smilde JG 2006Diabetes Care2006,29,:1
3Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes:the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in noninsulin-dependent diabetes mellitus(ASPEN)显示文摘Knopp RH d'Emden M Smilde JG 2006Diabetes Care2006,29,7:1
4Efficacy and safety of atorv-astatin in the prevention of cardiovascular end points in subjects withtype 2 diabetes:the Atorvastatin Study for Prevention of Coronary HeartDisease Endpoints in non-insulin-dependent diabetes mellitus(ASP-EN)显示文摘Knopp RH d'Emden M Smilde JG 2006Diabetes Care2006,29,7:1
5Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes:the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)显示文摘Knopp RH d'Emden M Smilde JG 0,,07:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费